
    
      The investigators will seek to recruit 20 patients diagnosed with muscle invasive localized
      urothelial carcinoma of the bladder who are scheduled to receive neo-adjuvant chemotherapy
      prior to RC from the Queen Elizabeth Health Sciences center in Halifax, Nova Scotia.
      Participants will be randomly allocated to standard of care treatment versus standard of care
      plus a multimodal, home-based program including strength and endurance exercises. Outcomes
      measured will include feasibility data, patient outcomes, and post-surgical complications.
    
  